Compositions and methods for the induction of retinal detachments
AssigneeISTA Pharmaceuticals, Inc.
InventorHampar L. Karageozian
Life of this patent
Estimating the term…
Abstract
A method comprising administering by ocular route a dose of a glycol ether effective to induce retinal detachment.
Claims16
Use of a glycol ether in the manufacture of a medicament to induce retinal detachment.
Use of a glycol ether in the manufacture of a medicament to induce a non-surgical retinal translocation wherein the medicament is administered in a retinal detaching dose, wherein the detached retina is translocated from a first position to a second position, and the detached retinal tissue is then reattached.
Use of a glycol ether in the manufacture of a medicament to protect detached retinal tissue from degeneration.
A method comprising administering by ocular route a dose of a glycol ether effective to induce retinal detachment.
A method comprising the steps of:
- administering by ocular route a dose of a glycol ether effective to induce retinal detachment;
- translocating a portion of retinal tissue from a first position to a second position;
- and
- reattaching said portion of retinal tissue.
A method of protecting a detached retina comprising administering by ocular route a dose of a glycol ether effective to protect photoreceptor cells in a segment of a detached retina.
Dependencies are inferred from the claim text.